262 related articles for article (PubMed ID: 28228073)
1. Principal Physicochemical Methods Used to Characterize Dendrimer Molecule Complexes Used as Genetic Therapy Agents, Nanovaccines or Drug Carriers.
Alberto RFR; Joao R; de Los Angeles MM; Alberto MM; Manuel Jonathan FV; José CB
Curr Pharm Des; 2017 Aug; 23(21):3076-3083. PubMed ID: 28228073
[TBL] [Abstract][Full Text] [Related]
2. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
3. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in dendrimer-based nanocarriers.
Bai S; Thomas C; Rawat A; Ahsan F
Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer nanocarriers as versatile vectors in gene delivery.
Dutta T; Jain NK; McMillan NA; Parekh HS
Nanomedicine; 2010 Feb; 6(1):25-34. PubMed ID: 19450708
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
Yellepeddi VK; Ghandehari H
Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
[No Abstract] [Full Text] [Related]
7. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.
Kesharwani P; Iyer AK
Drug Discov Today; 2015 May; 20(5):536-47. PubMed ID: 25555748
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.
Palmerston Mendes L; Pan J; Torchilin VP
Molecules; 2017 Aug; 22(9):. PubMed ID: 28832535
[TBL] [Abstract][Full Text] [Related]
9. Theoretical Studies for Dendrimer-Based Drug Delivery.
Bello M; Fragoso-Vázquez J; Correa-Basurto J
Curr Pharm Des; 2017; 23(21):3048-3061. PubMed ID: 28245759
[TBL] [Abstract][Full Text] [Related]
10. Dendrimers for pharmaceutical and biomedical applications.
Yang H; Kao WJ
J Biomater Sci Polym Ed; 2006; 17(1-2):3-19. PubMed ID: 16411595
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in multifunctional dendrimer-based complexes for cancer treatment.
Shcharbin D; Zhogla V; Abashkin V; Gao Y; Majoral JP; Mignani S; Shen M; Bryszewska M; Shi X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1951. PubMed ID: 38456205
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
13. Dendrimers in gene transfection.
Shcharbin DG; Klajnert B; Bryszewska M
Biochemistry (Mosc); 2009 Oct; 74(10):1070-9. PubMed ID: 19916919
[TBL] [Abstract][Full Text] [Related]
14. Host-guest chemistry of dendrimer-drug complexes. 3. Competitive binding of multiple drugs by a single dendrimer for combination therapy.
Zhao L; Cheng Y; Hu J; Wu Q; Xu T
J Phys Chem B; 2009 Oct; 113(43):14172-9. PubMed ID: 19788172
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in dendrimer-based nanomedicine development.
Kim Y; Park EJ; Na DH
Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on dendritic architectures and their biological applications: From core to cell.
Viswanath V; Santhakumar K
J Photochem Photobiol B; 2017 Aug; 173():61-83. PubMed ID: 28564631
[TBL] [Abstract][Full Text] [Related]
17. Multiscale Molecular Simulations Applied to Nucleic Acid-Dendrimer Interactions Studies.
Márquez-Miranda V; Araya-Durán I; González-Nilo FD
Curr Pharm Des; 2017 Aug; 23(21):3062-3075. PubMed ID: 28266272
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of poly(propylene imine)-dendrimer-grafted gold nanoparticles as nanocarriers of doxorubicin.
Golshan M; Salami-Kalajahi M; Mirshekarpour M; Roghani-Mamaqani H; Mohammadi M
Colloids Surf B Biointerfaces; 2017 Jul; 155():257-265. PubMed ID: 28433942
[TBL] [Abstract][Full Text] [Related]
19. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
Leiro V; Garcia JP; Tomás H; Pêgo AP
Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
